Filing Details
- Accession Number:
- 0001415889-22-002589
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 18:46:48
- Reporting Period:
- 2022-03-02
- Accepted Time:
- 2022-03-04 18:46:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1726419 | Stephany Verstraete | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Marketing Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-03-02 | 1,808 | $0.00 | 24,086 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-03-02 | 3,074 | $0.00 | 27,160 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-03-02 | 773 | $0.00 | 27,933 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-03-02 | 1,147 | $0.00 | 29,080 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-03-02 | 868 | $0.00 | 29,948 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-03-03 | 2,858 | $70.24 | 27,090 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2022-03-02 | 1,808 | $0.00 | 1,808 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2022-03-02 | 3,074 | $0.00 | 3,074 | $0.00 |
Common Stock | Performance Stock Units | Acquisiton | 2022-03-02 | 1,545 | $0.00 | 1,545 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2022-03-02 | 773 | $0.00 | 773 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2022-03-02 | 1,147 | $0.00 | 1,147 | $0.00 |
Common Stock | Performance Stock Units | Acquisiton | 2022-03-02 | 2,602 | $0.00 | 2,602 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2022-03-02 | 868 | $0.00 | 868 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,807 | No | 4 | M | Direct | ||
3,072 | No | 4 | M | Direct | ||
1,545 | No | 4 | A | Direct | ||
772 | No | 4 | M | Direct | ||
2,295 | No | 4 | M | Direct | ||
2,602 | No | 4 | A | Direct | ||
1,734 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
- On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
- Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021.
- The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022.
- On March 2, 2022, the reporting person earned 1,545 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
- On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- Performance award amount determined based on metrics in respect of the issuer's 2021 financial results.
- The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022.
- On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.